<DOC>
	<DOCNO>NCT01656434</DOCNO>
	<brief_summary>The purpose study assess contraceptive efficacy nomegestrol acetate + 17ß-estradiol ( NOMAC-E2 ) combine oral contraceptive ( COC ) healthy , sexually-active American woman risk pregnancy . Vaginal bleeding pattern woman take NOMAC-E2 assess compare woman take norethisterone acetate + ethinyl estradiol ( NETA-EE ) COC . The safety NOMAC-E2 also assess . Participants randomize receive either NOMAC-E2 NETA-EE 3:1 ratio . As Amendment 1 ( increase sample size NOMAC-E2 group ) , randomization ratio adapt accordingly participant randomize sample size increase .</brief_summary>
	<brief_title>Study Contraceptive Efficacy Safety NOMAC-E2 Combined Oral Contraceptive ( COC ) ( P06448 )</brief_title>
	<detailed_description>This study terminate early . The decision terminate study base upon difficulty encounter data collection ( related incomplete e-Diary entry ) concert business consideration . The decision relate new unexpected safety efficacy finding NOMAC-E2 . As result early termination , none pre-specified efficacy endpoint analyze .</detailed_description>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Ferrous fumarate</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>Sexually active woman , risk pregnancy need contraception Not plan use contraceptive method ( include barrier method [ e.g. , condom ] ) study drug , study Willing use COC 12 month ( 13 cycle ) Body mass index ( BMI ) ≥18 &lt; 38 kg/m^2 Good physical mental health Willing complete electronic diary daily basis duration study Current smoker age &gt; 35 year Presence history either venous thromboembolic disease ( deep vein thrombosis [ DVT ] , pulmonary embolism ) arterial thromboembolic disease ( myocardial infarction , stroke ) History migraine focal neurological symptom Diabetes mellitus vascular involvement Less two week full remobilization prolong immobilization , major surgery , surgery leg , major trauma Severe hypertension Severe abnormal lipoprotein blood Pancreatic dysfunction Presence history severe liver disease liver tumor Known suspect sex steroidinfluenced malignancy ( e.g. , genital organ breast ) Undiagnosed vaginal bleeding Known suspect pregnancy Current history abuse alcohol drug ( e.g. , laxatives ) Abnormal cervical smear screen Prior start treatment , spontaneous menstruation occur follow delivery abortion Breastfeeding breastfeeding within 2 month prior start treatment Use investigational drug and/or participation clinical trial within 2 month prior start treatment Use follow medication prior study may prohibit inclusion : sex hormone ( pre posttreatment noninjectable contraceptive ) , injectable hormonal contraception , phenytoin , barbiturate , primidone , bosentan , carbamazepine , topiramate , felbamate , rifampicin , ritonavir , nevirapine , efavirenz , griseofulvin , herbal remedy contain Hypericum perforatum ( e.g. , St. John 's wort )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Combined Oral Contraceptives</keyword>
</DOC>